Totura, A.L., Whitmore, A., Agnihothram, S., Schäfer, A., Katze, M.G., Heise, M.T., et al. (2015) Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection. mBio, 6, e00638.
https://mbio.asm.org/content/6/3/e00638-15

has been cited by the following article:

• TITLE: Saudi Scientific Diabetes Society Position Statement: Management of Diabetes Mellitus in the Pandemic of COVID-19

  AUTHORS: Abdulrahman Alshaikh, Saud Alsifri, Amani Alhozali, Hala Mosli, Tarif Zawawi, Seraj Mira, Emad R. Issak

  KEYWORDS: COVID-19, Diabetes Mellitus, Glycemic Target, Blood Glucose Control

  JOURNAL NAME: International Journal of Clinical Medicine, Vol.11 No.5, April 28, 2020

  ABSTRACT: About 10% coronavirus (COVID-19) infected patients are with diabetes comorbidity. Also, diabetes promotes severe progression in COVID-19 patients. Diabetes comorbidity is associated with significant mortality in those people with COVID-19. In this position statement, the management of diabetes in cases of COVID-19, has been presented. The impact of diabetes on the morbidity and mortality of COVID-19, as well as both the target glucose level and the method of blood glucose control have been presented in details.